Atossa Therapeutics
ATOS
#10514
Rank
โ‚น2.01 B
Marketcap
โ‚น201.82
Share price
3.92%
Change (1 day)
181.61%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -โ‚น21.52

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น23.80. In 2024 the company made an earnings per share (EPS) of -โ‚น19.04 an increase over its 2023 EPS that were of -โ‚น22.85.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น21.5213.04%
2024-โ‚น19.04-16.67%
2023-โ‚น22.8514.29%
2022-โ‚น19.9916.67%
2021-โ‚น17.14-90.86%
2020-โ‚น187.54-2.96%
2019-โ‚น193.26-63.09%
2018-โ‚น523.60-49.63%
2017-โ‚น1,040-57.87%
2016-โ‚น2,468-74.01%
2015-โ‚น9,493-9.18%
2014-โ‚น10,453-12.86%
2013-โ‚น11,99570.73%
2012-โ‚น7,02634.08%
2011-โ‚น5,240263.47%
2010-โ‚น1,442

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น831.70-3,594.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น872.98-3,768.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1,081-4,644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น79.97 236.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น19.99-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA